20 June 2013
Keywords: update, blow, aventis/genta, fda, says, data, genasense
Article | 10 May 2004
The US Food and Drug Administration's Oncologic Drugs Advisory Committee has said that, with no evidence of increased survival shown ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 May 2004
11 October 2004
19 June 2013
© 2013 thepharmaletter.com